Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoerfeireqing (小儿肺热清) is a traditional Chinese medicine (TCM) formulation primarily used in pediatric populations for the treatment of respiratory conditions such as acute bronchitis and cough associated with "lung heat" syndromes. The formula typically contains a combination of herbal ingredients designed to clear heat from the lungs, relieve cough, and reduce phlegm. Clinical studies and meta-analyses suggest that it can improve symptoms and overall effectiveness when combined with conventional Western therapies for acute pediatric bronchitis[3]. Its mechanism of action is based on TCM principles—clearing lung heat and resolving phlegm—but specific molecular targets are not well characterized in modern pharmacology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xiaoerfeireqing.